ArticleEndocrine2024

Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.

Manila Rubino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.